Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Iscience|June 26, 2020
A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1Yanan Li, Ying Cheng, Maoqi Zhang, et al.Organic Letters|December 18, 2012
A safe and facile route to imidazole-1-sulfonyl azide as a diazotransfer reagentHui Ye, Ruihua Liu, Dongmei Li, et al.Frontiers in Pharmacology|November 17, 2022
Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanomaQian Zhao, Teng Wang, Huanhuan Wang, et al.Journal of Medicinal Chemistry|October 28, 2005
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in ratsConrad W Hummel, Andrew G Geiser, Henry U Bryant, et al.European Journal of Cancer (Oxford, England : 1990)|March 13, 2024
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanomaXiaoting Wei, Zhengyun Zou, Weizhen Zhang, et al.Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2James F Blake, John J Gaudino, Jason De Meese, et al.Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safetyTimothy I Richardson, Scott A Frank, Minmin Wang, et al.Pageof 4